Accessibility Menu
 
Q32 Bio logo

Q32 Bio

(NASDAQ) QTTB

Current Price$5.08
Market Cap$78.56M
Since IPO (2024)-68%
5 Year-95%
1 Year+249%
1 Month-2%

Q32 Bio Financials at a Glance

Market Cap

$78.56M

Revenue (TTM)

$53.74M

Net Income (TTM)

$33.24M

EPS (TTM)

$2.66

P/E Ratio

2.02

Dividend

$0.00

Beta (Volatility)

0.96 (Low)

Price

$5.08

Volume

3,114

Open

$5.52

Previous Close

$5.37

Daily Range

$5.08 - $5.53

52-Week Range

$1.34 - $8.04

QTTB News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Q32 Bio

Industry

Biotechnology

Employees

24

CEO

Jodie P. Morrison

Headquarters

Waltham, MA 02451, US

QTTB Financials

Key Financial Metrics (TTM)

Gross Margin

99%

Operating Margin

40%

Net Income Margin

62%

Return on Equity

157%

Return on Capital

40%

Return on Assets

52%

Earnings Yield

49.50%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$78.56M

Shares Outstanding

14.63M

Volume

3.11K

Avg. Volume

287.98K

Financials (TTM)

Gross Profit

$53.35M

Operating Income

$16.90M

EBITDA

$17.29M

Operating Cash Flow

$33.54M

Capital Expenditure

$0.00

Free Cash Flow

$33.54M

Cash & ST Invst.

$48.30M

Total Debt

$15.34M

Q32 Bio Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$90.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$78.56M

N/A

Market Cap/Employee

$2.81M

N/A

Employees

28

N/A

Net Income

$7.61M

+31.0%

EBITDA

$7.63M

+28.1%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$39.76M

-14.8%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$4.75M

-64.8%

Short Term Debt

$6.24M

+17.9%

Return on Assets

52.21%

N/A

Return on Invested Capital

40.39%

N/A

Free Cash Flow

$6.34M

+49.2%

Operating Cash Flow

$6.34M

+49.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
VRCAVerrica Pharmaceuticals Inc.
$7.44-6.88%
GBIOGeneration Bio Co.
$5.34+0.00%
SABSSAB Biotherapeutics, Inc.
$3.69-10.10%
BOLDBoundless Bio, Inc.
$1.55+7.64%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$77.23+0.01%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$42.06-0.01%
DGXXDigi Power X
$7.55+0.14%
TSDDGraniteShares ETF Trust - GraniteShares 2x Short Tsla Daily ETF
$6.87-0.08%

Questions About QTTB

What is the current price of Q32 Bio?

Q32 Bio is trading at $5.08 per share.

What is the 52-week range for Q32 Bio?

Over the past 52 weeks, Q32 Bio has traded between $1.35 and $8.05.

How much debt does Q32 Bio have?

As of the most recent reporting period, Q32 Bio reported total debt of $13.65M.

How much cash does Q32 Bio have on hand?

Q32 Bio reported $50.75M in cash and cash equivalents in its most recent financial results.

What is Q32 Bio’s dividend yield?

Q32 Bio does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.